Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Gloperba

Drug Analgesic

NDC 75854-801-01

Open in the dashboard

General payments

$204,266

344 payments

Research payments

$0

0 payments

Through program year 2025, $204,266 in general payments and $0 in research payments were reported against Gloperba (Analgesic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $115,363 117
2024 General $79,303 224
2023 General $9,600 3

Breakdown

Who paid General payments · program years 2023–2025
  1. Scilex Pharmaceuticals Inc. $204,266 344 payments
Top recipients General payments · program year 2025
  1. Srinivas Nalamachu Physical Medicine & Rehabilitation · Overland Park, KS $110,923 96% · 18 payments
  2. Angelo Gaffo Llontop Rheumatology · Birmingham, AL $2,550 2% · 1 payment
  3. Amber Seeler Nurse Practitioner, Family · Victor, NY $61 <1% · 3 payments
  4. Nilamadhab Mishra Rheumatology · Winston Salem, NC $44 <1% · 2 payments
  5. Khanh Ho Rheumatology · Baton Rouge, LA $40 <1% · 2 payments

The top 5 of 86 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Physical Medicine & Rehabilitation $110,923 96% · 1 practitioner
  2. Rheumatology Internal Medicine $3,524 3% · 43 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $218 <1% · 9 practitioners
  4. Internal Medicine $187 <1% · 8 practitioners
  5. Physician Assistant $144 <1% · 8 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Kansas $110,923 96% · 1 recipient
  2. Alabama $2,550 2% · 1 recipient
  3. North Carolina $334 <1% · 15 recipients
  4. Georgia $330 <1% · 14 recipients
  5. New Jersey $313 <1% · 14 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

344 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record